The Effect of Pulsed Electromagnetic Field Therapy on Muscle Mass and Muscle Strength in Prostate Cancer Patients Treated With Androgen Deprivation Therapy
Recruiting · NCT07057375 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Pulsed electromagnetic fields ThearpySham Therapy
What this trial is about
This study is to assess the effect of Pulsed electromagnetic fields (PEMF) on improving muscle mass and strength in prostate cancer patients with ADT.
Who can take part
Age range
18 Years and older
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adult patients with age greater than or equal to 18 years old.
- Histologically documented PCa
- No evidence of distant metastasis (M1 disease)
- With ADT exposure from six months to three years
- Expected to continue for at least six months
- At least four weeks after radical prostatectomy or completed radiotherapy
Exclusion criteria
- Patients are still under active treatment, such as radiotherapy
- Patients who are unable to walk for 400 m or undertake exercise that will affect the clinical assessment of muscle strength
- Patients with amputated lower limbs or other body deformities that will affect the treatment protocol
Where it is running
1 location listed.
- Prince of Wales Hospital - Shatin, Hong Kong